Covid-19 Update: For more information on how ENTA is taking extra precautions to provide the safest environment possible during the COVID-19 pandemic, please click here.
COVID-19 Series I: www.XENTlivestream.com
COVID-19 Series II: www.XENTwebinar.com
Dr. Moshe Ephrat is a fellowship trained and Board Certified ENT surgeon having over 20 years of expertise with specialized interests in nasal/sinus surgery, rhinoplasty and facial rejuvenation. Dr. Ephrat was awarded and completed a fellowship devoted to facial plastic and reconstructive surgery.
Dr. Ephrat has academic appointments as an Assistant Clinical Professor for the Mount Sinai School of Medicine as well as the Zucker School of Medicine at Hofstra/Northwell. He also has held a leadership position as the President of the Long Island Society of Otolaryngology – Head and Neck Surgery. His media appearances include The Dr. Oz Show, CBS news and News 12 Long Island. Dr. Ephrat maintains membership in many national, state and local societies including the AAFPRS, AAOHNS, LISO, ARS, and MSSNY.
Dr. Ephrat is consistently among the first in the area to offer new breakthrough medical technologies. Patients with chronic sinusitis, nasal obstruction and nasal polyps can now be treated In-Office with state of the art equipment, including the Medtronic Image Guidance System, allowing unparalleled patient safety. This allows patients relief without general anesthesia and quicker recovery. The Vivaer procedure is offered to patients with nasal obstruction and nasal valve collapse.
Educational videos and images may be watched on his social media sites including YouTube: DrEphratVideo, Instagram @DrEphrat and @PolypDoc. These sites allow exploration of the variety of treatments Dr. Ephrat manages both in the office and the operating room theater.
Some of the cutting edge technologies that Dr. Ephrat uses to manage nasal polyps and chronic sinusitis include 3D image guidance sinus surgery, PolypVac / suction powered debriders, PROPEL family of self-dissolving implants, SINUVA implant and topical steroid treatments to avoid the unwanted effects of systemic steroids.
Dr. Ephrat is also in the forefront of clinical research and recently published results of a research trial used in the FDA approval of a novel new treatment for nasal valve collapse and nasal obstruction - The Vivaer procedure is minimally invasive and requires 15 minutes in the office (https://onlinelibrary.wiley.com/doi/full/10.1002/lio2.247) He will also be a principal investigator in a research trial for a medical treatment used for nasal polyps.
Published On: 12/16/2011
Published On: 12/05/2011
Published On: 10/22/2010